Voluntarily discontinued distribution of Tilray's cannabis oil capsules in Croatia

Cannabis oil capsules likely damaged in shipping causes routine product discontinuation of Tilray's cannabis oil capsule in Croatia

Editor's note: This article has been edited to note this was a product discontinuation, not a recall.

Only ten days after they were first released, a batch of Tilray’s cannabis oil capsules was discontinued in Croatia, according to Croatian press reports.

The Croatian Institute of Immunology and Tilray, in agreement with the Croatian of Ministry of Health, voluntarily discontinued distribution of the products. The Croatian Institute of Immunologyand Tilray are working diligently to import replacement products as soon as possible.

The damaged products did not pose a health or safety risk for patients, and patients who had products in their possession at the time were instructed to continue to use any products that were in their possession.

Reports noted that capsules in several pharmacies appeared to have been damaged or cracked, likely from improper shipping. Tilray was notified at the time and was ready to replace the oils.

The Ministry of Health carried out the sampling and drug samples submitted for analysis to the Agency for medicines and medical products , and to the results of analysis of distribution and dispensation of preparations based on cannabis has been temporarily suspended ," the Acting Director, noting that the content of intact capsules was absolutely correct and that they meet the prescribed quality requirements. FROM informed the manufacturers, the company Tilray from Canada, which is ready to replace the damaged capsules.

In some pharmacies we heard as provided that such capsules are in dark glass bottles, while they get them in plastic containers, and that they are looking for smaller packs of 30. Price for 30 lower dosage capsules was 920 kuna, and for the same amount of a stronger concentrate 1,200 kuna. Apparently it is a small number sold to patients with prescriptions.

"The recalled bottles are 200 capsules with liquid filling Tilray Cannabis Sativa with 5.0 mg THC / 5.0 mg CBD and bottles of 200 capsules with liquid filling Tilray Cannabis Sativa with 2.5 mg THC / 2 , 0 mg CBD, and due to quality defect of the drug class III (variation in weight of the product caused damage to the capsule during transport).

Manufacturers will supply products withdrawn from the product as an oil in a 25 ml bottle with dispenser. Replacement oil in 25 ml bottle with dispenser will be the formulation of 5.0 mg THC / 5.0 mg CBD, or 2.5 mg THC / 2.5 mg CBD, "says the Institute of Immunology .

This is the first product of it’s kind exported by a Canadian Licensed Producer. No Canadian LPs yet offer capsules for Canadian patients, although several producers are expected to release some soon.

UPDATED: Sept 29: Tilray provided this response early today:

The Croatian Institute of Immunology and Tilray, in agreement with the Croatian of Ministry of Health, discontinued distribution of two batches of cannabis extract capsules due to damage sustained by the products during transportation. The damaged products did not pose a health or safety risk for patients, and patients who had products in their possession at the time were instructed to continue to use any products that were in their possession. The Institute of Immunology and Tilray are working diligently to import replacement products as soon as possible.

Featured image via Tilray.ca

In this article

Join the Conversation